JNK India Targets 25–30% FY27 Revenue Growth

JNK India Limited — Q4 & FY26 Earnings Call (held May 21, 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly emphasizes “strong numbers,” “strong quarter,” “disciplined execution,” and “well-positioned.”
• Forward-looking language is confident: “we expect a revenue growth of around 25% to 30% in FY27,” and “quite bullish and quite confident” on the JV.

2. Key Themes from Management Commentary

• Strong FY26 growth + profitability expansion
• FY26 revenue Rs. 838 cr (+68%); operating profit Rs. 212.3 cr (+45%); EBITDA margin improved to 13.3%.
• Margin normalization narrative (accounting/project mix)
• EBITDA margin expansion attributed to project mix and closure of legacy orders, with “14% to 15% is what basically is the normal EBITDA.”
• Order book strength and execution visibility
• Order inflows Rs. 1,694.4 cr; total order book Rs. 1,961.4 cr as of Mar 31, 2026.
• Heavy concentration: heating equipment ~94% of order value; India ~97.5% of order book.
• Clean energy / JV expansion (Chemdist)
• JV “JNK Chemdist Technologies” contributed ~7% of group revenue in its first year (with ~6 months of operations).
• Management expects JV contribution to rise to 10%–15% over the next couple of years (qualitatively tied to technology commercialization).
• Export-led pipeline
• Management highlights export opportunities (Africa/Middle East/Russia) and expects pipeline finalizations over 2–3 quarters.
• Cash flow improvement focus
• Operating cash flow historically negative but management signals improvement and working-capital efforts.

3. Q&A Analysis

Theme A: EBITDA margin drivers + “normalized” run-rate

• Core questions
• How much margin expansion is due to project mix shift (service vs supply) vs other factors?
• What is the normalized EBITDA run-rate for FY27?
• Management response
• Margin expansion mainly due to project mix and accounting method timing: legacy projects completed earlier; newer projects recognized under the “input accounting method.”
• “14% to 15% is what basically is the normal EBITDA… we should expect in this range.”
• Also stated they aim to keep margins “around similar lines… about 14% and 15%.”
• Assessment
• Relatively direct answer; however, it relies on accounting/mix normalization assumptions (not purely operational pricing power).

Theme B: Dangote Phase 2 / fertilizer / refinery timelines

• Core questions
• Status of RFQs/prequalification; expected finalization timing for fired heaters and reformers.
• Competition landscape and expected order timing.
• Management response
• Prequalification received; fired heater finalization expected in Q1 FY27, reformer in Q2/Q3.
• Competition: Dangote accepts only “very reputed suppliers”; Heurtey not quoting for EPC now; other European bidders exist but management expects “fair” competition.
• Refinery part expected finalized in Q1 (June/July).
• Assessment
• Strong specificity on timing for FY27, but still conditional (“expected,” “looks like,” “weeks here and there”).

Theme C: Domestic bid pipeline (BPCL Bina, IOCL/Haldia/MRPL) + crude/geopolitics impact

• Core questions
• When will bids open for domestic projects?
• Any impact from geopolitical/commodity pricing and ability to pass through?
• Management response
• Domestic bidding expected to take ~6 months to 1 year due to “current situations” and “crude oil pricing… affecting Indian refiners.”
• Commodity/geopolitics: “not impacted us much” last quarter except shipment delays; they take a “conservative approach” and avoid “too much of a positive side on the EBITDA margin.”
• Assessment
• Cautious language on margin upside; acknowledges macro/price uncertainty.

Theme D: Cash flow / working capital conversion

• Core questions
• When will operating cash flow turn positive?
• Conversion period for unbilled revenue; PSU vs private customer payment terms.
• Management response
• Operating cash flow: improvement continues; “positive… at least” and they expect it to be positive in FY27 (explicitly asked).
• Unbilled revenue conversion: expected in ~three months; primarily from new projects (cracker furnace/process plants) and “primarily from private customer only.”
• Explanation: earlier negative cash flow due to PSU skewed payment terms; now more private/export orders with better down-payment terms.
• Assessment
• More credible than margin guidance because it ties to customer mix and timing; still no hard numeric cash-flow target.

Theme E: Execution capability, capacity utilization, capex

• Core questions
• Can they execute Rs. 2,000–2,500 cr sales/orders in a year?
• Capex needs and facility utilization (Mundra/export facility; domestic fabrication outsourcing).
• Management response
• Execution capability supported by backlog (~Rs. 1,961 cr) and typical ~2-year execution gestation.
• Capex: “Rs. 10 crores, Rs. 15 crores” for a smaller domestic facility; “don’t really need much of a capex.”
• Capacity bottleneck is manpower/engineering + working capital, not fabrication facilities (fabrication can be outsourced).
• Assessment
• Generally consistent; however, relies on outsourcing and working-capital availability (key sensitivities).

Theme F: JV (Chemdist) growth, order book, margins, capex

• Core questions
• How will JV revenue/order book scale from ~7% contribution?
• JV margin trajectory and whether technology is commercially proven.
• JV capex and pipeline.
• Management response
• JV order book ~Rs. 70 cr included in consolidated backlog.
• JV bid pipeline ~Rs. 200 cr (chemical/pharma/water-related equipment/tech projects).
• Margin improvement: currently competitive because tech not yet commercially proven; margin improvement expected only after commercialization (“it will take maybe a couple of years more”).
• Capex: “Rs. 10 crores to Rs. 15 crores.”
• Assessment
• Clear conditionality: growth target is confident, but margin upside is explicitly delayed by commercialization.

Theme G: Order inflow targets / win rate / conversion

• Core questions
• Order inflow target, win rate, and how much converts to revenue in the same year.
• Bid pipeline size and expected order book by next year.
• Management response
• Conversion rate: “25% to 30%” of bid pipeline; expected order book addition Rs. 1,300–1,500 cr.
• Revenue ramp: first two quarters minimal booking; Q3 onwards revenue starts booking; Q4 heavy.
• Order book: hopes to cross ~Rs. 2,000 cr next year (from ~Rs. 1,900 cr now).
• Assessment
• Provides a mechanistic conversion framework; still no explicit win-rate sensitivity.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 revenue growth: “around 25% to 30%”
• Normalized EBITDA margin range: “14% to 15%” (also “endeavour to keep margin around similar lines… Q3 and Q4”)
• Capex (incremental facility): “Rs. 10 crores, Rs. 15 crores”
• Order conversion / addition expectation: bid conversion “25% to 30%”; order book addition “Rs. 1,300 crores to Rs. 1,500 crores”
• Operating cash flow: asked if positive in FY27; management: “it is positive… at least” and implies improvement continuing (no numeric).

Implicit signals (qualitative)

• Margin upside is capped by conservatism: management says they don’t want to “do too much of a positive side on the EBITDA margin.”
• Seasonality persists: Q4 “heaviest,” Q1 lowest.
• Export scaling is expected to increase: bid pipeline increasingly export-heavy; Middle East/Russia opportunities highlighted.
• Cash flow improvement depends on project mix: private/export terms vs PSU skew.

5. Standout Statements (direct quotes where useful)

• Margin normalization: “14% to 15% is what basically is the normal EBITDA… we should expect in this range.”
• FY27 growth guidance: “we expect a revenue growth of around 25% to 30% in FY27.”
• Cash flow turning positive: “can we see that number turning positive in FY27?” → “it is positive… at least” (operating cash flow).
• JV confidence but margin delay: “we are quite bullish and quite confident” on Chemdist; but “technologies are not yet commercially… Only after that, we could see a margin improvement.”
• Conservatism on macro/margins: “we don’t want to do too much of a positive side on the EBITDA margin. So, we are doing a bit conservative approach.”
• Order book strength: “order book… Rs. 1,961.4 crores as of 31 March, 2026.”

6. Red Flags / Positive Signals

Red flags
– Accounting/mix dependence for margin normalization: EBITDA “normal” is tied to input accounting method and legacy closure, not purely operational pricing power.
– Concentration risk: order book heavily skewed to heating equipment (~94%) and India (~97.5%).
– Cash flow guidance is non-numeric and depends on working capital/project timing; prior history includes negative operating cash flow.

Positive signals
– Clear, repeatable margin target (14%–15%) and explicit linkage to project mix normalization.
– Order book + inflow visibility with quantified conversion assumptions (25%–30%).
– JV traction already showing revenue contribution (~7% in ~6 months).

7. Historical Comparison & Consistency Analysis

a. Change in Tone Over Time

• Current (Q4/FY26): more confident/optimistic—strong numbers + explicit FY27 growth and margin range.
• Prior (Q3 FY26, Feb 2026): also optimistic, but more emphasis on policy tailwinds and JV progress; less explicit “normalized EBITDA run-rate.”
• Shift classification: More Optimistic
• Current call gives tighter operational framing: “normal EBITDA 14%–15%,” and more concrete FY27 revenue growth.
• Less discussion of macro/policy than Q3; more focus on execution and run-rate.

b. Tracking Past Commitments vs Outcomes

1) Margin guidance normalization / accounting-method impact
– Past (Q3 FY26, Feb 2026): management said margins were “historically around this range” and that recent lower margins were due to legacy projects and accounting method differences; expected “normal margins now.”
– Current (Q4/FY26): reiterates normalization and quantifies “14% to 15% normal EBITDA.”
– Flag: ✅ Delivered/Aligned (margin range narrative strengthened with actual Q4/FY26 results).

2) Chemdist JV ramp
– Past (Q3 FY26): JV expected to generate “significant long-term value”; revenue contribution referenced as early progress.
– Current: JV already contributed ~7% of group revenue in first year (~6 months operations) and expects 10%–15% contribution for first couple of years.
– Flag: ✅ Delivered/On Track (early revenue contribution is now evidenced).

3) Dangote timing expectations
– Past (Q3 FY26): Dangote inquiries expected within “one or two quarters,” order finalization around Q3 (per analyst framing; management did not fully lock exact dates).
– Current: fired heaters expected finalized in Q1 FY27, reformers Q2/Q3; refinery part Q1.
– Flag: ⏳ Partially Delayed / Re-timed (timeline moved from “around Q3” to more spread across Q1/Q2/Q3 FY27; still “expected,” not confirmed).

c. Narrative Shifts

• From policy tailwinds → execution/run-rate
• Q3 call leaned on Union Budget/policy (green hydrogen mission, excise exemptions, CCUS incentives).
• Q4 call shifts to project pipeline execution, margin run-rate, and cash conversion mechanics.
• JV narrative becomes more operational
• Q3: JV as critical long-term strategy.
• Q4: JV already contributing revenue and has quantified order book/bid pipeline and capex.

d. Consistency & Credibility Signals

• Medium-to-High credibility
• Consistent: margin normalization tied to legacy closure + accounting method across calls.
• Credibility improved by providing quantified run-rate and conversion assumptions.
• Still, several items remain “expected” (Dangote, domestic bid timing, Russia stuck projects), so execution risk is not fully eliminated.

e. Evolution of Key Themes

• Margins: improving/stabilizing; now explicitly guided to 14%–15% as sustainable.
• Demand/pipeline: remains strong; order book increased to ~Rs. 1,961 cr.
• Clean energy/JV: moving from announcement to measurable contribution and pipeline.
• Cash flow: improving trend acknowledged; still historically negative and guidance remains qualitative.

f. Additional Insights (Cross-Period Intelligence)

• Margin “normalization” is increasingly framed as accounting/mix timing, which can mask underlying operational pricing power. Management is careful not to overpromise (“conservative approach”).
• Export pipeline is becoming more central in the narrative (Q4 mentions export opportunities ~Rs. 4,000 cr bidding), suggesting a strategic shift away from purely domestic PSU-driven cycles.
• Cash flow improvement is tied to customer mix (private/export vs PSU)—a structural lever, but it also implies that if PSU terms return, cash conversion could deteriorate.